Introduction {#Sec1}
============

Liver disease in childhood is rare and is frequently the cause of dismay as the medical care provider attempts to recall the myriad of diagnoses that they read about during their training but may never have encountered. In the minds of most, jaundice or elevated liver function tests equals liver disease, but many questions tend to surface: What is the etiology? Can referral wait until more diagnostic information is available? What are the appropriate tests to do and how urgently? What is the likely progression and are there potentially life-threatening consequences of delayed diagnosis and treatment? None of these questions can be answered without formulating a reliable differential diagnosis.

The aim of this chapter is to describe hepatic disease phenotypes based simply on age and primary manifestation of liver disease such as cholestasis, hepatomegaly, or acute liver failure (see Table [6.1](#Tab1){ref-type="table"}) and to provide a reasonably comprehensive list of hepatic diseases that may present with these clinical phenotypes. The hope is to help primary medical providers determine the differential diagnosis and thus guide early studies and appropriate referral and pediatric gastroenterologists and trainees to determine a comprehensive differential diagnosis for their patients on which to base a rational work-up and management plan. This chapter is not intended to be a plan for the detailed investigation of a child with liver disease or a commentary on the probability of any given diagnosis when encountering a patient that fulfils a particular clinical phenotype, but to list the diagnoses that have been recognized, even if only very rarely. Any schema describing the investigations to work through a differential diagnosis is dependent on local conditions dictated by resource availability, priorities, and the probability of a specific diagnosis. For example, in the northwest of the USA, dengue fever would not be included in most differential diagnoses of a local patient, but in Southeast Asia, this would be a major priority.Table 6.1List of clinical phenotypes in pediatric patients with liver involvementThe sick infant in NICU with other known disease (frequently a premature infant with respiratory distress syndrome or chronic lung disease of prematurity and often on parenteral feeding support) (a) Congenital ascites with hepatomegaly or hepatosplenomegaly (b) Hemorrhage (e.g., gastrointestinal or intracranial) with coagulopathy or low platelets (c) Necrotizing enterocolitis or surgical resection for congenital bowel malformation (d) Hepatomegaly or liver dysfunction associated with congenital heart disease or heart failure (e) An abdominal mass (f) Cholestatic jaundice or abnormal transaminasesThe sick infant in the emergency room or transferred from another hospital (a) Hepatitis -- acute hepatitis or fulminant hepatic failure (b) Metabolic decompensation -- acidosis, hyperammonemia, or hypoglycemia (c) Abdominal mass with heart failure or Kasabach-Merritt syndrome (d) Hepatomegaly and abnormal liver function with systemic infectionThe stable infant referred to clinic with liver disease (a) Cholestasis (b) Elevated liver function tests (c) Hepatomegaly (d) Abnormalities found on ultrasound (e) Asymptomatic infant of mother with chronic viral hepatitis (f) Asymptomatic sibling of child with known liver diseaseYounger child with liver involvement (cholestasis, transaminitis, and/or hepatomegaly) (a) Acute hepatitis (b) Presentation of a chronic liver disease  (i) Jaundice  (ii) Ascites  (iii) Gastrointestinal bleeding (c) Hepatomegaly or hepatosplenomegaly on routine exam (d) Abdominal mass (e) Elevated liver function tests on routine screening or tests drawn for other reasons (f) Abnormal liver or spleen finding on abdominal ultrasound done for other reasonsOlder child/adolescent with liver involvement (cholestasis, transaminitis, and/or hepatomegaly) (a) Acute hepatitis (b) Presentation of a chronic liver disease  (i) Jaundice  (ii) Ascites  (iii) Gastrointestinal bleeding (c) Hepatomegaly or hepatosplenomegaly on routine exam (d) Abdominal mass (e) Elevated liver function tests on routine screening or tests drawn for other reasons (f) Abnormal liver or spleen finding on abdominal ultrasound done for other reasonsAcute liver failure (a) Acute hepatitis with coagulopathy and encephalopathyConsult from other specialties with liver dysfunction in association with known disease (a) Gastroenterology  (i) Abnormal liver function or hepatomegaly associated with known gastrointestinal disease, e.g., inflammatory bowel disease or celiac disease  (ii) Transaminitis or cholestasis in children on long-term parenteral nutrition for intestinal failure (b) Cardiology  (i) Ascites (often chylous) with Fontan circulation  (ii) Hepatosplenomegaly, abnormal LFTs, or ascites-associated heart failure  (iii) Ischemic hepatitis (shock liver) and acute liver failure post-cardiac surgery  (iv) Alagille syndrome (c) Hematology/oncology  (i) Liver dysfunction associated with liver tumor  (ii) Cholestasis, elevated transaminases, and hepatomegaly in child with hematologic disease, e.g., sickle-cell anemia  (iii) Hepatitis and/or cholestasis associated with chemotherapeutic agents  (iv) Hepatitis and/or cholestasis following bone marrow/stem cell transplantation (d) Pulmonology  (i) Liver diseases in patients with cystic fibrosis  (ii) Hepatitis in patients with other pulmonary diseases, e.g., sarcoidosis, histoplasmosis, or tuberculosis (e) Nephrology  (i) Hepatomegaly and splenomegaly associated with polycystic kidney disease  (ii) Cholestasis or abnormal liver function and tubulointerstitial nephritis/nephronophthisis  (iii) Portal hypertension associated with IgA nephropathy or membranoproliferative glomerulonephritis (f) Endocrine  (i) Hyperlipidemic and obese patients with abnormal transaminases  (ii) Hepatomegaly and transaminitis in poorly controlled diabetics  (iii) Cirrhosis in patients with generalized lipodystrophy (g) Immunology  (i) Hepatitis or cholestasis in children with defined immunodeficiency syndromes  (ii) Granulomatous hepatitis in chronic granulomatous disease (h) Rheumatology  (i) Hepatitis associated with lupus, other generalized autoimmune conditions, juvenile idiopathic arthritis, and macrophage activation syndrome (i) Genetics  (i) Liver abnormalities as part of a dysmorphic or multisystem syndromeOthers: Isolated splenomegaly, unconjugated jaundice, isolated ascites, itching, hemorrhage, or hypocalcemia and rickets

Hepatology patients range from day-old premature infants to 18-year-old young adults and from seemingly healthy children in the outpatient clinic to profoundly sick infants in the intensive care unit (ICU) on life support. The best way to determine a diagnosis safely and efficiently is to develop a deep understanding of the pathophysiology of liver disease, but even for the most experienced, a checklist of diagnostic possibilities may be helpful to ensure no oversights.

Physicians have always suspected a patient of having disease of the liver from a relatively limited number of clinical signs or symptoms, namely, jaundice, a palpable liver mass or generalized hepatomegaly, splenomegaly, or ascites \[[@CR1]\]. Within the last century, blood test abnormalities \[[@CR2]\] or aberrant anatomical findings on imaging, commonly sonography, have suggested liver problems prior to the appearance of clinical signs. Patients commonly have other features of disease such as hypoglycemia, metabolic bone disease, or anemia, and these additional features do indeed constitute the patient's disease phenotype and aid with the refining of a differential diagnosis. However, one should be wary of attempting to define precise and detailed liver disease phenotypes because they may fail to take into account the great variability in how individual disease states may be manifest and consequently lead to a diagnosis being overlooked if not "classical" in its presentation.

Disclaimer {#Sec2}
==========

The goal of this chapter is to form the basis of an organized list of diseases of the pediatric liver. It is likely that the most significant gaps will relate to extremely rare hepatological diagnoses and multisystem genetic syndromes with occasional incidental hepatic associations.

Many diagnoses are the subject of detailed discussion in other chapters (and cross-reference will be included where appropriate); however, the more esoteric and unusual may require other resources for in-depth review.

Clinical Assessment: The Importance of a Careful History and an Expert Physical Examination {#Sec3}
===========================================================================================

The value of careful history taking cannot be overemphasized. It is important to understand the timing and the evolution of the features of liver disease, as well as any symptoms originating outside of the liver and gastrointestinal tract. A full inquiry about birth and pregnancy history, previous medical history, family history, and social history is crucial and should include any exposure to drugs and dietary supplements; household, garden, or garage products; and complementary medicinal products. Similarly, a careful history of contact with infectious disease, foreign travel, and occupational exposure should be obtained. It is important to examine the urine and stool color if possible or, at a very minimum, have the parents describe these colors; stool color charts have been designed for this purpose (see 10.1007/978-1-4614-9005-0_13). It is not adequate to ask them whether the urine and stools are normal.

Similarly a skilled physical examination will not only assist with making a prompt diagnosis but can save considerable cost to the care of the patient. Eliciting clinical signs on physical examination of a patient may not be easy, particularly with a squirming infant, a frightened toddler, a giggling child, or an overtly belligerent adolescent, but the skills must be well learned and then practiced patiently and conscientiously throughout one's career. It is not enough to expect the correct diagnosis to eventually reveal itself if a multitude of laboratory tests and imaging studies are ordered. In the absence of an expert physical examination, a child with ascites of cardiac origin may undergo multiple studies of the liver over many weeks before the correct etiology is recognized. Similarly the patient with pancytopenia, but in whom the modest splenomegaly is not recognized, may be investigated extensively (and expensively) in the hematology department before portal hypertension with hypersplenism is diagnosed.

In the clinical assessment of a patient with suspected liver disease, there are a number of general considerations to be taken into account when trying to formulate a differential diagnosis. The first of these is age at presentation, primarily because many diseases have a typical age (range) of onset. This may allow us to eliminate some diseases completely, for example, primary biliary cirrhosis has never been described in a young child, and to relegate the possibility of yet others, for example, hepatomegaly first encountered in an adolescent is unlikely to be due to glycogen storage disease. Evidence of liver disease present at birth may imply an intrauterine process such as defects of embryonic developmental genes, congenital infections, or isoimmune phenomena, whereas early postnatal disease may indicate an inborn error of metabolism or infection acquired perinatally.

The next general consideration is whether there is a predisposition to developing certain forms of liver disease, i.e., other medical conditions that may predispose to specific liver diseases such as primary sclerosing cholangitis in patients with preexisting ulcerative colitis or hepatoblastoma in a child with Beckwith-Wiedemann syndrome. Similarly the onset of liver disease during pregnancy such as HELLP (hypertension, elevated liver tests, and low platelets) syndrome or acute fatty liver of pregnancy may indicate metabolic disease in the fetus and usually carrier status in the woman. A detailed family history will help reveal potential familial predisposition such as parental consanguinity or a previous sibling with a single-gene defect. Occasionally there is manifestation of a heterozygous status in relatives such as cholelithiasis in the family of the child with MDR3 deficiency. In a patient suspected of having autoimmune hepatitis, a history in the extended family of other autoimmune conditions such as lupus or hypothyroidism is likely to be relevant.

Environmental exposure to infectious or toxic agents is another general consideration that may alter probabilities within a list of differential diagnoses. Infectious etiologies may gain priority due to an endemic risk at place of abode or recent travel to an at-risk area. A history of drinking or bathing in water from a local supply while traveling raises the possibility of a whole range of infectious agents capable of inducing liver injury. International travel is not, however, a prerequisite for unusual infections that may manifest as liver disease; for example, Histoplasma capsulatum, a cause of granulomatous hepatitis especially in the immunocompromised, is endemic in some central and southern US states \[[@CR3]\], and baylisascariasis, a rare cause of hepatomegaly and meningoencephalitis, has been described in young children who have ingested soil contaminated with raccoon feces \[[@CR4]\]. Knowledge that a mother has a chronic transmissible infection, particularly hepatitis B but also including hepatitis C, HIV, malaria, and Chagas disease \[[@CR5]\], may simplify the diagnosis of an infant with liver disease. Exposure to industrial toxins, particularly from pollutant spills, is usually reported, but particularly in the developing world, there may not be a full disclosure; therefore, direct questioning is essential. Also all drug exposures should be assessed including herbal and homeopathic remedies and dietary supplements. Ingestion of wild mushrooms is a particular risk. Amanita species are found in many parts of the world, while other foods collected straight from nature may be either directly toxic or chemically contaminated. Not all effects of environmental exposure occur immediately upon exposure; minocycline-induced autoimmune hepatitis takes a period of 12--20 months from initiation of treatment for teenage acne, for instance, before liver dysfunction appears \[[@CR6]\].

Triggering factors are specific environmental exposures that do not cause disease but reveal its presence. Glycogen storage disease type 1 may become manifest only at weaning from breast-feeding or during an episode of poor intake due to intercurrent illness. Hereditary fructose intolerance may be revealed by the inadvertent administration of intravenous fructose or medicine containing sucrose or sorbitol \[[@CR7]\] and the administration of valproate to an infant with seizures due to an unrecognized mitochondrial cytopathy may trigger acute liver failure \[[@CR8]\].

Why Diagnosing Liver Disease May Be Difficult {#Sec4}
=============================================

Pediatric liver disease is not common in the general practitioners' experience, and therefore, the diagnoses and its diagnostic work-up may be relatively unfamiliar. Additionally, although established liver disease is rare, it is not uncommon to see mild abnormalities of liver function tests. In infants jaundice is frequently seen in the form of physiologic neonatal jaundice and breast milk jaundice. Although these causes manifest as unconjugated hyperbilirubinemia, it does mean that the mere presence of jaundice in a newborn infant does not necessarily raise the suspicion of liver disease. The difficulties of diagnosis are doubly increased when dealing with acute liver failure; not only are there severe constraints on the time available for a full diagnostic work-up but hepatic metabolic function is severely deranged, sometimes making the differentiation between primary and secondary metabolic abnormalities virtually impossible by biochemical means. Fortunately there are now much greater nucleic acid-based options for primary diagnosis of specific inborn errors of metabolism, but results can take time to become available. Another concern in the early detection of pediatric liver disease relates to the difficulty of maintaining basic clinical examination skills in an age of advanced imaging techniques. The ability of the physician to use hands and eyes to detect clinical signs such as hepatomegaly, ascites, and cutaneous features of liver disease needs to be carefully nurtured among medical students and junior medical staff. Finally, there are a number of terms that are commonly used in regard to liver disease that mean the diagnosis has not been identified such as "idiopathic" fulminant hepatic failure, "cryptogenic" cirrhosis, and "neonatal hepatitis." It is important to remember that these are not diagnoses but an admission that the diagnostic work-up has failed to identify the primary cause of liver disease. The acceptance of these terms as seemingly discreet diseases may be in some way responsible for incomplete diagnostic work-up. Narkewicz et al. describe how frequently a suboptimal diagnostic work-up is seen in children presenting with acute liver failure when given a diagnosis of idiopathic liver failure even in the context of a multicenter study \[[@CR9]\].

Phenotypes {#Sec5}
==========

The Sick Newborn {#Sec6}
----------------

Most consultations done for suspected liver disease in the newborn nursery or neonatal intensive care are on infants with other reasons to be there and have not yet been home. Less frequently their primary reason is because of liver dysfunction at or within days of birth. Liver dysfunction may be inherent from congenital infection or inborn error of metabolism or secondary to other peri- or postnatal events such as ischemia, necrotizing enterocolitis, congenital heart disease, abdominal surgery, or the need for parenteral feeding.

Clinical features which may indicate liver disease include ascites, hyperammonemia, hypoglycemia and coagulopathy, hepatomegaly with or without splenomegaly, cholestasis, and abnormal liver function tests. Congenital liver disease may result in early fetal loss, but the classical presentation is the hydropic infant with hepatomegaly, congenital ascites, hypoalbuminemia, coagulopathy, and very-early-onset cholestasis. These findings are not specific for primary congenital liver disease as congenital ascites is commonly due to severe fetal anemia, both isoimmune and nonimmune causes such as alpha thalassemia, or fetal heart failure, and is mostly seen in the setting of generalized hydrops fetalis (see Table [6.2](#Tab2){ref-type="table"} for a more complete list of causes). When primary liver disease is suspected, an important diagnosis to consider is "neonatal hemochromatosis." Studies by Whitington and colleagues have demonstrated that the majority of these cases are due to a maternal factor (presumably an IgG alloantibody) crossing the placenta and inducing complement-mediated hepatocellular injury, one result of which is excessive iron deposition \[[@CR10]\]. This immune-mediated "neonatal hemochromatosis" condition has been renamed *gestational alloimmune liver disease* (GALD) (see 10.1007/978-1-4614-9005-0_10).Table 6.2Causes of congenital ascitesImmuneIsoimmune hemolytic disease of newbornGestational alloimmune liver disease (neonatal hemochromatosis)Congenital lupus erythematosusNonimmune anemiasOther hemolytic disorders affecting fetusDisorders of red cell production, e.g., α-thalassemiaCongenital leukemiaFetal hemorrhageTwin-to-twin transfusionInfectiousParvovirus B19Cytomegalovirus (CMV)SyphilisHerpes simplexToxoplasmosisHepatitis BAdenovirus*Ureaplasma urealyticumListeria monocytogenes*EnterovirusLymphocytic choriomeningitis virus (LCMV)ChromosomalCri-du-chat syndrome (chromosomes 4 and 5)Trisomy 13Trisomy 18Trisomy 21 (Down syndrome)Turner syndromeGenetic syndromesSmith-Lemli-Opitz syndromeBeckwith-Wiedemann syndromeKlippel-Trenaunay-Weber syndromeYellow nail syndromeMetabolicGlycogen storage disease, type IVGaucher disease, type IIMorquio disease (MPS IV)Hurler syndrome (MPS 1H)Sly syndrome (MPS VII)Farber diseaseG~M1~ gangliosidosisSialidosis III-cell diseaseNiemann-Pick type CWolmanInfantile sialic acid storage disorderPrimary carnitine deficiencyCongenital defects of glycosylationCardiovascularCongenital heart diseaseCongenital arrhythmiasCongenital myocarditisLiver tumorsHepatoblastomaMesenchymal hamartomaHemangioendotheliomaMiscellaneousIntussusceptionMeconium peritonitisLymphangiectasiaUrinary tract malformationsPlacental abnormalitiesTeratomaExtra-abdominal tumorsHypothyroidism and hyperthyroidism

There are also infants who were seemingly healthy at birth but within a few hours to a few days develop features of acute liver failure (see Table [6.3](#Tab3){ref-type="table"}) with coagulopathy and hyperammonemia. There is considerable overlap with the causes of congenital ascites although viral infection acquired at or around the time of birth is more likely, disseminated neonatal herpes simplex being a frequently encountered cause. Generalize septicemia and, in at-risk populations, congenital malaria may also present in this manner. Inborn errors of metabolism with infantile acute presentation may include lysosomal storage defects but are more likely to be defects of intermediate metabolism such as galactosemia, organic acidemias, and glycogen storage disease type I (see 10.1007/978-1-4614-9005-0_8). GALD may also present similarly although there is usually evidence of chronic liver disease. An important diagnosis to exclude, because liver transplantation is contraindicated, is hemophagocytic lymphohistiocytosis (HLH), but HLH characteristically has a more delayed onset with patients tending to present later in infancy (see 10.1007/978-1-4614-9005-0_12 and 10.1007/978-1-4614-9005-0_29). Severe liver dysfunction may be seen with vascular compromise as well, such as thrombosis of the inferior vena cava or hepatic veins, and with congenital portal vein anomalies. Heart failure secondary to congenital heart disease may result in an ischemic hepatitis, and rarely congenital leukemia or myelodysplasia can present with acute liver failure.Table 6.3Causes of acute liver failure in infancyInfectious ViralHerpes simplexVaricella zosterCytomegalovirusHuman herpes virus 6AdenovirusEnterovirusHepatitis BParvovirus B19Influenza BacterialSepticemia ProtozoalMalariaGeneticTyrosinemia type 1GalactosemiaHereditary fructose intoleranceFructose 1,6-bisphosphatase deficiencyOrganic acidemiasUrea cycle disordersFatty acid oxidation defectsMitochondrial/respiratory chain defectsCarnitine defectsNiemann-Pick type CGlycogen storage disease type 1ImmuneNeonatal hemochromatosisHemophagocytic lymphohistiocytosisAutoimmune hemolytic anemia with giant cell hepatitisVascularHeart failureCardiac surgeryIschemic hepatitisBudd-ChiariCongenital portal vein anomaliesNeoplasticInfantile leukemiaHemangioendotheliomaNutritional/toxicDrugs/toxinsOtherReye syndrome

Commonly, despite intensive work-up, no specific cause is found; however, as has been cautioned in the introduction, the diagnosis of "idiopathic" neonatal hepatitis should not be assumed until all recognized causes have been excluded (see 10.1007/978-1-4614-9005-0_12). Certainly the proportion of patients with this label of idiopathic neonatal hepatitis has fallen over the years with the discovery of novel conditions and disease mechanisms, and it is to be hoped that eventually the term will become unnecessary. Until then idiopathic neonatal hepatitis should be seen as a challenge to further diagnostic adventure rather than an end in itself.

Although not all infants in the neonatal unit with evidence of liver disease are as sick as patients with hydrops or acute liver failure, the differential diagnosis for hepatitis with or without cholestasis remains large (see Table [6.4](#Tab4){ref-type="table"}). Certainly the diagnoses that were entertained for the sicker group of infants may be found manifest with less severe disease; thus, congenital infection, storage disorders, and GALD still appear in the differential diagnosis for infants with simple cholestasis and elevated transaminases, but a larger spectrum of etiologies also needs to be considered including genetic and chromosomal syndromes that may be apparent from abnormal physical features, as well as vascular, endocrine, and neoplastic causes. Additionally, in those infants who have intestinal failure (usually related to surgical resection for necrotizing enterocolitis or congenital intestinal anomalies), cholestasis is related to enteral starvation and the need for intravenous feeding (see 10.1007/978-1-4614-9005-0_17). Less commonly iatrogenic causes of neonatal liver disease may be seen, such as portal vein thrombosis or extravasation of parenteral fluids into the liver substance (see Fig. [6.1](#Fig1){ref-type="fig"}) complicating umbilical venous catheterization \[[@CR11]\].Table 6.4Causes of hepatitis and/or cholestasis in infancyInfectious ViralHerpes simplexVaricella zosterCytomegalovirusHuman herpes virus 6AdenovirusEnterovirusHepatitis BRubellaParvovirus B19Human immunodeficiency virus (HIV) BacterialSyphilisListeriaSepticemiaUrinary tract infectionAcute cholecystitisAcute cholangitisPyogenic liver abscess FungalHepatosplenic candidiasisOther systemic fungemias ProtozoalMalariaToxoplasmosisCongenital Chagas diseaseImmuneNeonatal hemochromatosisHemophagocytic lymphohistiocytosisNeonatal lupusAutoimmune hemolytic anemia with giant cell hepatitisErythroblastosis fetalisGraft versus host syndromeAutoimmune hepatitisKawasaki diseaseMyeloproliferative disorderNutritional/toxicTPN/intestinal failureDrugs/toxins/herbalsBreast milk jaundiceIndian childhood cirrhosisOther copper toxicosesMetabolicCrigler-NajjarDubin-Johnson syndromeRotor syndromeTyrosinemia type 1GalactosemiaGlycogen storage diseasesOrganic acidemiasUrea cycle disordersCitrin deficiencyFatty acid oxidation defectsCholesterol synthesis defectsMitochondrial/respiratory chain defectsCongenital defects of glycosylationBile acid synthesis defectsPeroxisomal defectsNiemann-Pick type CLysosomal storage diseasesMucopolysaccharidosesAlpha 1-antitrypsin deficiencyCystic fibrosisDefects of biliary transport (PFIC)Familial cholanemiasErythropoietic protoporphyriaSyndromicTrisomy 21Trisomy 18Trisomy 13Cat-eye syndromeAlagille syndromeARC syndromeAagenaes syndromeDonohue syndromeMODY 5Jeune syndromeCOACH syndromeJoubert syndromeBardet-Biedl syndromeIvemark syndromeBeckwith-Wiedemann syndromeNISCH syndromeNorth American Indian childhood cirrhosisCri-du-chat syndromeGRACILE syndromeMcCune-Albright syndromeSepto-optic dysplasiaSmith-Lemli-Opitz syndromeEndocrinePanhypopituitarismHypothyroidismHypoadrenalismHyperinsulinismCardiovascularPortal vein thrombosisCongenital anomalies of portal veinIschemic hepatitisHeart failureHepatic artery-portal vein fistulaSinusoidal obstruction syndromeBudd-ChiariNeoplasticLangerhans cell histiocytosisHepatoblastomaLeukemiaOther primary or metastatic liver tumorsOthersCholedochal cystCholedocholithiasisBiliary atresiaInspissated bileSpontaneous perforation of bile ductUVC trauma and extravasationNeonatal sclerosing cholangitisCaroli disease Fig. 6.1Massive extravasation of PN solution from an umbilical venous catheter which migrated into the liver -- (**a**) axial and (**b**) coronal CT views

Although hepatomegaly, abnormal transaminase, and even cholestasis may be present in multisystem diseases, these may not be the key features on which the diagnosis is based. For example, in many lysosomal storage conditions, abnormal facies, neurological findings, skeletal malformations, or other tissue involvement may point to the diagnosis (a list of metabolic defects that have been associated with liver disease is shown in Table [6.5](#Tab5){ref-type="table"}). Certain syndromes such as ARC (arthrogryposis, renal anomalies, and cholestasis), Aagenaes, Donahue, or Beckwith-Wiedemann syndrome also have characteristic physical manifestations, and the presence of hepatomegaly or liver function abnormalities simply supports the diagnosis. Liver involvement in multisystem diseases may manifest in some infants with hepatomegaly alone and will be reliant upon a careful physical examination to identify the relevant finding. The request for a hepatological opinion in such circumstances is to determine if the findings are consistent with the primary diagnosis, if there is a second diagnosis responsible for the liver abnormalities observed, to estimate prognosis, and to advise on appropriate management of the liver dysfunction.Table 6.5Inborn errors for metabolism associated with hepatic manifestationsEnzyme defectsSpecific diseaseManifestationsDefects of bilirubin conjugationGilbertUHCrigler-NajjarUHDefects of carbohydrate metabolismGalactosemiaNC, ALF, CLDHereditary fructose intoleranceNC, ALF, CLDFructose 1,6-bisphosphatase def.NC, ALFPEPCKDS, RGSD 1aHM, T, adenomaGSD3HM, T, CLDGSD4NC, T, CLDGSD6HM, TGSD9HM, TGlycerol-3-phosphate dehydrogenase deficiency 1HM, TDefects of amino acid metabolismTyrosinemia type1NC, ALF, CLD, HCCs-Adenosylhomocysteine hydrolaseNC, CLDMaple syrup urine diseaseNCMethylmalonic acidemiaR, HMPropionic acidemiaRIsovaleric acidemiaR3-MethylcrotonylglycinuriaR3-OH-3-methylglutaryl-CoA lyase def.RHolocarboxylase synthase def.R(Urea cycle disorders)N-Acetylglutamate synthase def.RCarbamoylphosphate synthase def.ROrnithine transcarbamylase def.RCitrullinemiaRArgininosuccinic aciduriaR, TDefects of fatty acid oxidationVLCAD def.HM, RLCHAD def.T, R, ALFMCAD def.R3-Hydroxyacyl-CoA dehydrogenase def.R, ALFDefects of ketogenesis3-HMG-CoA lyaseHMDefects of carnitine metabolismPrimary carnitine deficiencyHM, RDefects of mitochondrial metabolismMitochondrial DNA mutationsNC, T, ALF, R, CLDMitochondrial DNA deletionsNC, T, ALF, R, CLDMitochondrial DNA depletionNC, T, ALF, R, CLDRespiratory chain defectsT, R, ALF, CLDMultiple Acyl-CoA dehydrogenase def.HM, RPeroxisomal defectsZellweger syndromeNC, T, HM, CLDNeonatal adrenoleukodystrophyNC, T, HM, CLDInfantile RefsumNC, T, HM, CLDPipecolic acidemiaNC, T, HM, CLDBifunctional protein def.NC, T, HM, CLDDefects of lipoprotein metabolismTangier diseaseHM, SMAbetalipoproteinemiaHM, SDefect of cholesterol synthesisCerebrotendinous xanthomatosisNCSmith-Lemli-Opitz syndromeNCMevalonate kinase def.NCLysosomal storage diseasesGM1 gangliosidosisHM, SMGM2 (Sandhoff) gangliosidosisHM, SMNiemann-Pick A and BHM, SMNiemann-Pick CNC, SM, CLD, HCCGaucherHM, SMFarberHM, SMLysosomal acid lipase def. (Wolman and CESD)NC, T, S, HM, SM, CLDMucopolysaccharidoses (I, II, III, IV, VII)HM, SMMultiple sulfatase def.HM, SMI-cell diseaseHM, SMPseudo-Hurler polydystrophyHM, SMAspartylglucosaminuriaHM, SMFucosidosisHM, SMα-MannosidosisHM, SMSialidosisHM, SMGalactosialidosisHM, SMInfantile sialic acid storage diseaseHM, SMCongenital defects of glycosylationType I subtypes a, b, hNC, T, HM, SM, CLDType II subtypes b, e, hNC, T, HM, SM, HSMPorphyriasErythropoietic protoporphyriaT, CLDDefects of bile acid metabolismCerebrotendinous xanthomatosisNC3β-Hydroxy-Δ~5~-C^27^-steroid oxidoreductase def.NC, T, CLDOxysterol 7α-hydroxylase def.NC, T, CLD2-Methylacyl-CoA racemase def.NC, T, FSVMBAAT def. (bile acid CoA:amino acid N-acyltransferase)NC, T, FSVM, PTJP2 def. (tight junction protein)FSVM, PEpoxide hydrolase def.FSVM, PEndoplasmic reticulum storage diseasesα~1~-Antitrypsin def.NC, T, CLDFibrinogen storage diseaseT, CLDHereditary amyloidosisT, HM, CLDDefects of metal metabolismWilson diseaseT, HM, ALF, CLDHemochromatosisT, CLD, HCC*Transporter defects*Defects of bilirubin transportDubin-Johnson syndromeNCRotor syndromeNCDefects of biliary transportFIC1 def. (PFIC 1)NC, T, CLDBSEP def. (PFIC 2)NC, T, CLD, HCCMDR3 def. (PFIC 3)NC, T, CLDDefects of carbohydrate transportGSD1bHM, T, adenomaFanconi-BickelHM,Defects of amino acid transportHHH syndromeRCitrin def.NC, T, S, RLysinuric protein intoleranceRDefects of ion transportCystic fibrosisNC, T, CLDDefects of carnitine transportCarnitine-acylcarnitine translocase deficiencyHM, S, CLDCarnitine palmitoyltransferase II deficiencyHM, S, R, CLDCarnitine palmitoyltransferase I deficiencyHM, S, RSplenomegaly, fat-soluble vitamin malabsorption, and pruritus are only designated if the feature is present in the absences of fibrotic liver disease*NC* neonatal cholestasis, *UH* unconjugated hyperbilirubinemia, *T* elevated hepatic transaminases, *S* steatosis, *HM* hepatomegaly, *SM* splenomegaly, *ALF* acute liver failure, *CLD* chronic fibrotic liver disease, *HCC* hepatocellular carcinoma, *FSVM* fat-soluble vitamin malabsorption, *P* pruritus

The Sick Infant {#Sec7}
---------------

Infants discharged from the nursery presenting within days of birth with acute liver failure (see Table [6.3](#Tab3){ref-type="table"}) (see 10.1007/978-1-4614-9005-0_23) have a large diagnostic overlap with those who have been seen as a consultation presenting in the newborn period. Inborn errors of metabolism, perinatally acquired infection, GALD, and other conditions may have an apparent period of health prior to postnatal decompensation.

The history collected from family must include preceding signs and symptoms, details of the pregnancy and delivery, a dietary history with attention to weaning, fasting and recent feed changes, and consideration of possible precipitating exposures along with a family history, noting any consanguinity of the parents.

Infants have limited responses to severe illness, and the complaints from family may be nonspecific and include poor feeding, vomiting, lethargy, and seizures. There is little in the physical examination that will differentiate cause in such cases, but it is important to remember that many of the diagnoses may result in multisystem involvement and not just liver failure. Therefore, investigation should also be directed at detecting encephalitis, myocarditis, renal failure, adrenal and thyroid insufficiency, and almost any other tissue involvement. Significant encephalopathy in infants is more likely to be due to primary metabolic encephalopathy or infectious encephalitis, as hepatic encephalopathy tends to occur in infants only very late in the course of their liver disease, if at all.

While investigating the specific diagnosis is important, the most urgent need is to respond to the immediate threats to life. Empiric antibacterial and antiviral medications should be considered once appropriate cultures (blood, urine) and viral studies (herpes simplex) have been collected. Manage hypoglycemia, fluid and electrolyte imbalance, and acidosis if present. Intravenous fluids must supply adequate glucose to prevent catabolism, while defects of protein or lipid metabolism (or both as in glutaric aciduria type II) are being investigated -- hepatic glucose release for healthy infants may be in the range of 12--14 mg/kg/min, and therefore, this should be the delivery rate to prevent hypoglycemia and endogenous protein catabolism. Coagulopathy may be very severe without outward signs, so it is imperative to check coagulation profile with initial suspicion of liver dysfunction. Occasionally biliary atresia or other cholestatic infantile conditions present acutely with hemorrhage or ecchymoses secondary to vitamin K deficiency.

For details on diagnostic workup and management, see 10.1007/978-1-4614-9005-0_23.

The Stable Infant with Liver Disease {#Sec8}
------------------------------------

The infant referred to clinic with jaundice in the first few weeks of life is another common scenario for the general pediatrician and pediatric gastroenterologist. The general pediatrician sees more children with unconjugated hyperbilirubinemia secondary to prolonged physiologic jaundice or breast milk jaundice than they do children with cholestatic jaundice. Infants with unconjugated hyperbilirubinemia have colorless urine and pigmented stools (yellow-green or brown) \[[@CR12]\]. It is important to recognize that infants without conjugated hyperbilirubinemia do not pass yellow or amber urine because they drink at least 100 mL/kg/day and therefore pass dilute urine, unlike adults who frequently pass more concentrated yellow urine. Unconjugated jaundice still needs to be investigated if it is either very early in onset, prolonged beyond 10--14 days, very high levels, or of late onset. If breast milk jaundice is suspected and there is no evidence of hemolysis or infection, thyroid function is normal, and bilirubin levels are not progressively increasing, breast-feeding does not need to be discontinued. However, if the bilirubin level continues to rise, defects of bilirubin conjugation (Crigler-Najjar syndrome) should be considered. The high frequency of unconjugated jaundice in the infant population is one factor that has been suggested for late referrals of infants with biliary atresia; the rare case of conjugated hyperbilirubinemia is like a proverbial needle in the haystack of infants with unconjugated jaundice! It is important for the general pediatrician to remain alert to the possibility that an infant's jaundice is cholestatic and request split bilirubin levels -- total and direct or better still conjugated and unconjugated bilirubin levels (see 10.1007/978-1-4614-9005-0_3).

Referrals to the pediatric gastroenterologist or hepatologist are most commonly for conjugated hyperbilirubinemia, although the type of jaundice is not always characterized before referral. Due to the importance of a timely hepatoportoenterostomy to the prognosis of the affected infant, the diagnosis of biliary atresia needs to be ruled out promptly. There has been much discussion on the best combination of sonography, scintigraphy, liver biopsy, and cholangiography (see 10.1007/978-1-4614-9005-0_13), but efficiency of work-up demands a certain degree of experience in the team and institution caring for the infant. If it is not possible to make this diagnosis in a few days, the infant should be transferred to a center that has the required experience and where the appropriate surgical expertise exists to proceed to portoenterostomy. There is no justification for delaying transfer until the diagnosis is certain.

The investigations for other causes of infantile liver disease should be carried out concomitantly with the evaluation for biliary atresia. The priorities depend on the most likely causes relevant to the population served. Citrin deficiency, for example, is a relatively common cause of neonatal cholestasis in Japan and China but rare in Northern Europe, while for α~1~-antitrypsin deficiency and cystic fibrosis, the relative regional prevalence is reversed. It is wise to have an established protocol for first-line investigations according to your particular population, followed by a second line of investigations for less frequently encountered conditions and finally the very rare causes investigated sequentially to make best use of both patient's and hospital's resources.

Quite frequently a healthy, asymptomatic infant with proven or suspected perinatally acquired hepatitis B or hepatitis C will be referred to clinic for confirmation of diagnosis, management, and parental counselling. The child may be accompanied by natural parents, but often the patient may be brought to clinic by a foster family and the child's social worker or by the adoptive parents in the case of an adoptee from a region of the world where HBV is endemic. See 10.1007/978-1-4614-9005-0_15 for an approach to these infants. Another group of asymptomatic infants seen in clinic with liver-related questions include those with siblings affected by an inheritable liver disease whose parents either wish this child to be tested or who is already known to carry the mutation(s) and are seeking advice (e.g., α~1~-antitrypsin deficiency).

Rarely a family seeks medical attention because they have either identified a lump in the abdomen or notice abdominal distention. More commonly nonspecific features such as poor feeding or growth, vomiting, sweatiness, or tachycardia may first bring the infant to medical attention. Occasionally hepatomegaly with or without splenomegaly may be identified as one feature of multisystem genetic disorders such as a cilial dysfunction syndrome (see 10.1007/978-1-4614-9005-0_14) or a lysosomal storage disorder. In yet others, a completely asymptomatic mass may be identified on routine examination during a well-baby check. It is not always easy, especially in infants, to determine if an enlarge liver is due to diffuse enlargement of the liver or due to a circumscribed lesion or lesions.

The investigation of these infants depends largely on whether there is homogenous hepatic enlargement or the finding of a mass or masses arising from the liver (see Table [6.6](#Tab6){ref-type="table"}). Ultrasound findings are the best guide to further diagnostic approach. Bland hepatomegaly would point to the possibilities of hepatitis, metabolic storage, outflow obstruction as in heart failure, or syndromic organomegaly (e.g., Beckwith-Wiedemann syndrome). Discrete lesions on imaging imply tumor, cyst, or abscess. Undoubtedly, further imaging can help refine the diagnosis in these cases (see 10.1007/978-1-4614-9005-0_5), and some lesions may have highly characteristic findings on well-conducted studies. Delaying referral to an experience center is not usually beneficial and can result in multiple nonuseful investigations being carried out. Early referral to an experience center who can direct an appropriate diagnostic workup (10.1007/978-1-4614-9005-0_22) is recommended. For those without diagnostic findings on imaging, the lesions may need histological evaluation, and therefore, biopsy is necessary.Table 6.6Infant with a liver massBenign tumorHemangiomaInfectiousAmebic abscessInfantile hemangioendotheliomaPyogenic liver abscessMesenchymal hamartomaAdenomaTraumaticHepatic hematomaFluid extravasation from UVCMalignant tumorHepatoblastomaOtherCholedochal cystRhabdoid tumorMucocele of gall bladderRhabdomyosarcomaSimple hepatic cystNeuroblastomaRiedel's lobeOther hepatic malignancy

Young Child with Liver Disease (1--4 Years) {#Sec9}
-------------------------------------------

Most patients with newly recognized liver disease (see Table [6.7](#Tab7){ref-type="table"}) in this age range will present with hepatitis (inflammation of the liver) recognized by the primary provider because of elevated liver function tests. The blood tests are usually provoked by some combination of new onset of jaundice, fever, anorexia, vomiting, or malaise, although in a significant number of cases may be found on testing for nonspecific complaints of headache or abdominal pain or even on routine well-patient screening.Table 6.7Causes of cholestasis in the younger child (1--4 years)Infectious ViralHepatitis AHepatitis BHepatitis CCytomegalovirusEpstein-BarrAdenovirusParvovirus B19 BacterialUrinary tract infectionSepticemiaAcute cholangitisPyogenic abscessLeptospirosis ParasiticMalariaTrematodes (liver fluke)AscariasisHydatid (Echinococcus)Amebic abscessImmuneAutoimmune hepatitisSclerosing cholangitisKawasaki diseaseGraft versus host diseaseImmunodeficienciesMetabolicα~1~-Antitrypsin deficiencyTyrosinemiaFIC1 def. (PFIC1)BSEP def. (PFIC2)MDR3 def. (PFIC3)Peroxisomal defectsMitochondrial defectsCholesteryl ester storage diseaseDubin-Johnson syndromeRotor syndromeErythropoietic protoporphyriaSyndromicAlagille syndromeCiliopathies (e.g., COACH, Bardet-Biedl)NISCH syndromeNorth American Indian childhood cirrhosisMulibrey nanismTubulointerstitial nephropathy with cholestasisToxicDrugs/toxins/herbalsCopper toxicosisVascularBudd-ChiariSinusoidal obstruction syndromeConstrictive pericarditisHeart failureCongenital heart diseaseLiver traumaNeoplasticLangerhans cell histiocytosisTumors of liver or bile ductsLeukemiaOtherCholedochal cystCaroli diseaseCholedocholithiasisSickle-cell disease

Causes of hepatitis include infectious, commonly viral, autoimmune, and some metabolic diseases which had escaped detection in earlier life. Children with chronic viral hepatitis (hepatitis B and hepatitis C) contracted from the mother at birth may remain completely asymptomatic and be detected during investigation of other complaints, especially if the mother has not been previously diagnosed and had suboptimal antenatal care. This is particularly applicable to young children from high endemic risk areas of the world (recent immigrants and adoptees) and mother's with a history of at-risk behaviors such as intravenous substance abuse. Autoimmune hepatitis can occur at any age, but in this age group, liver-kidney-microsomal (LKM) antibody-positive disease constitutes a larger proportion of cases than is seen in older children (see 10.1007/978-1-4614-9005-0_16). Kawasaki disease, although rarely seen in GI clinic, very commonly has abnormal transaminases and bilirubin levels at presentation. Similarly, children with celiac disease may have abnormal transaminases, but these tend to resolve upon diagnosis and initiation of a gluten-free diet.

Chronic liver diseases with a gradual progression may be first revealed in the young child, as in some cases of α-1-antitrypsin deficiency (see 10.1007/978-1-4614-9005-0_9) and Alagille syndrome (see 10.1007/978-1-4614-9005-0_11). Despite there being no history of neonatal cholestasis, these diseases may progress silently to fibrotic liver disease, detected either by the astute primary doctor finding splenomegaly on routine examination or with the first onset of complications of cirrhosis or portal hypertension.

In the developed world, the infectious causes of liver disease are relatively limited especially in the essentially healthy child, but in the tropics, there are many more pathogens that may induce deranged liver function (see Table [6.8](#Tab8){ref-type="table"}). On the other hand, obesity is now endemic (and some have said epidemic) in the developed world driven by excessive nutritional intake and an increasingly sedentary lifestyle. Nonalcoholic fatty liver disease is now regularly being diagnosed as early as second year of life (see 10.1007/978-1-4614-9005-0_18). Lastly, drug-induced or toxic hepatitis may result from inadvertent ingestion by the adventurous toddler or due to an idiosyncratic reaction to prescribed medication (see 10.1007/978-1-4614-9005-0_19) (see Table [6.9](#Tab9){ref-type="table"}).Table 6.8Infectious agents associated with hepatic involvement*ViralBacterialFungal*Hepatitis AUrinary tract infectionHistoplasmosisHepatitis BSepticemiaHepatosplenic candidiasisHepatitis CAcute cholangitisDisseminated aspergillosisHepatitis DAcute cholecystitisTrichosporon cutaneumHepatitis EPyogenic abscessPenicillium marneffeiHerpes simplexPerihepatitis (gonorrhea, chlamydia)CoccidioidomycosisVaricella zosterToxic shock syndrome (staphylococcus)CryptococcosisCytomegalovirusScarlet feverEpstein-Barr virusSalmonella typhi/paratyphi*Protozoal*Human herpes virus 6ShigellaToxoplasmosisHuman herpes virus 7YersiniaMalariaHuman herpes virus 8Clostridium perfringensAmebic abscessRubellaBrucellosisToxocariasisAdenovirusListeriosisCryptosporidiumEnterovirusBorrelia (Lyme borreliosis)Chagas diseaseParvovirus B19LeptospirosisLeishmaniasisParamyxovirusSyphilisBabesiosisReoviruses (Colorado tick fever)Bartonella (cat scratch, Carrion disease)Influenza/parainfluenzaActinomycosis*Parasitic*Coronavirus (SARS)LegionellaClonorchiasisHuman immunodeficiency virus (HIV)TularemiaFascioliasisYellow feverMelioidosisOpisthorchiasisDengue feverTuberculosisDicrocoelium dendriticumOther flavivirus hemorrhagic feverLeprosyParagonimiasisLassa feverRocky Mountain spotted feverSchistosomiasisLymphocytic choriomeningitis virusScrub typhusEchinococcus (hydatid disease)Other arenavirus hemorrhagic feversEhrlichiosisAscariasisFilovirus fevers (Ebola, Marburg)Q feverStrongyloidesHantavirus hemorrhagic feverTrichinellaOther bunyavirus hemorrhagic feversCapillariasisBaylisascariasis Table 6.9Pharmaceuticals and toxins that have been reported to cause liver diseaseAntibioticsAnticonvulsants and CNS-acting drugsChemotherapeuticsMiscellaneous drugsWild plants/herbalsDietary supplements and recreational drugsNon-medicinal chemicalsAmoxicillin/clavulanateCarbamazepineMethotrexateAcetaminophenAmanitaVitamin ACarbon tetrachlorideFlucloxacillinLamotrigineAzathioprineAlcoholComfreyHydroxy CutChlorobenzeneSulfonamidesPhenobarbital6-MercaptopurineAllopurinolPyrrolizidine alkaloidsEcstasyVinyl chlorideErythromycinPhenytoinCyclophosphamideAmiodaroneSenna glycosidesCocaineOther organic solventsAzithromycinValproatePropylthiouracilEstrogensGermanderPyrrolizidine alkaloidsCephalosporinsFelbamateNitrosoureasAnabolic steroidsChaparralYellow phosphorusMinocyclineAtomoxetinecis-PlatinumAspirinKava-kava2-NitropropaneNitrofurantoinChlorpromazineMany othersDiclofenacJin bu huanCopperIsoniazidMethyldopaRarely used singlyKetoprofenEphedra (ma huang)IronRifampinFluoxetineIbuprofenQuinine/quinolonesNaproxenAzole antifungalsHalothaneAntiretroviralsTroglitazoneCyclosporinPemolineCimetidine

Non-hepatic causes of laboratory abnormalities and clinical signs and symptoms typically attributed to liver disease must also be considered. Although abnormal "liver" function tests equate in most practitioners' mind to liver disease, there are important exceptions. "Transaminitis" without jaundice is commonly seen in diseases of skeletal and cardiac muscle. The inclusion of γ-glutamyl transferase and creatine kinase (or other muscle-derived enzyme such as aldolase) can help differentiate the tissue source of elevated levels of AST and ALT. Duchenne muscular dystrophy is a particularly important diagnosis to consider. Another cause of elevated transaminase levels in the absence of liver disease is due to macroenzymes (especially macro-AST) \[[@CR13]\]. Serum enzymes may complex with immunoglobulins resulting in a high molecular weight complex that has a prolonged half-life because of reduced plasma clearance. Although macroenzymes have been associated with acute, chronic, and malignant liver disease, most cases appear benign and self-limiting although the triggers for formation are not fully understood. Benign (or transient) hyperphosphatasia is frequently seen in young children possibly provoked by a mild intercurrent illness \[[@CR14]\]. The alkaline phosphatase level can peak in the thousands and remains elevated for a few weeks to a few months before settling to the normal range. If the isoenzymes of alkaline phosphatase are assayed, the largest increase is seen in bone-derived isoenzyme although liver isoenzyme can be increased as well. In the absence of bone disease (e.g., rickets or fracture) and otherwise normal liver laboratory values, no further investigation is required.

Jaundice may be secondary to acute hemolysis; for example, a child with the glucose-6-phosphate dehydrogenase "favism" variant may be first exposed to broad (fava) beans as a young child and present with new-onset jaundice. Even massive ascites may not be what it seems; Fig. [6.2](#Fig2){ref-type="fig"} shows the CT appearance of a young child with a giant omental cyst.Fig. 6.2Pseudo-ascites due to giant omental cyst -- (**a**) sagittal and (**b**) coronal CT views

Hepatomegaly or a liver mass may turn out to be the anatomical variant, Riedel's lobe, an elongated right lobe. Incidental hepatomegaly is the likely presenting feature for the benign glycogen storage diseases due to phosphorylase and phosphorylase kinase deficiency (GSD VI and IX, respectively). Sizable liver masses, however, at this age are likely to be primary hepatoblastoma, neuroblastoma, or other abdominal malignancy (see 10.1007/978-1-4614-9005-0_22). Hepatocellular carcinoma (HCC) occurs in association with advanced chronic liver disease and in conditions with a specific predisposition such as tyrosinemia and PFIC type 2 but is vanishingly rare as a de novo tumor in an otherwise healthy young child. Benign lesions are most commonly detected on abdominal imaging that was done for other indications and, as discussed for infants, early referral to an experienced center will expedite appropriate management.

Older Child/Adolescent with Liver Disease (\>5 Years) {#Sec10}
-----------------------------------------------------

Just like in the younger children, suspicion of liver disease arises from the appearance of specific symptoms such as jaundice, chance pickup on routine physical examination, or investigation of nonspecific and possibly unrelated medical concerns (see Table [6.10](#Tab10){ref-type="table"}). Acute hepatitis due to hepatitis A and Epstein-Barr virus (EBV) is relatively common and new infection with hepatitis B and hepatitis C becomes more common in adolescent populations. Hepatitis E in endemic areas rarely causes significant clinical disease in young children but is more likely to cause acute hepatitis as subjects' age and is particularly dangerous for the pregnant teenage girl (see 10.1007/978-1-4614-9005-0_15). Autoimmune hepatitis often presents with acute hepatitis and although more frequent in adolescent girls can occur in both sexes and at any age (see 10.1007/978-1-4614-9005-0_16). Most cases of Wilson disease diagnosed in childhood and adolescence manifest as acute, often fulminant, hepatitis, and although rare, an expedient diagnosis may prevent death or liver transplantation (see 10.1007/978-1-4614-9005-0_9).Table 6.10Causes of cholestasis in older children and adolescentsInfectious ViralHepatitis AHepatitis BHepatitis CHepatitis ECytomegalovirusEpstein-Barr virusAdenovirus BacterialSepticemiaAcute cholangitisPyogenic abscessLeptospirosisRocky Mountain spotted feverBorrelia (Lyme's)Salmonella typhi/paratyphiTuberculosis ParasiticMalariaTrematodes (fluke)AscariasisLeishmaniasisEchinococcus (hydatid)Amebic abscessCryptosporidiumMetabolicWilson diseaseCholesteryl ester storage diseaseBenign recurrent intrahepatic cholestasisJuvenile hemochromatosisHELLP syndrome (pregnant teenage women)ImmuneAutoimmune hepatitisSclerosing cholangitisPrimary biliary cirrhosisKawasaki diseaseGraft versus host diseaseImmunodeficienciesSystemic lupus erythematosusSarcoidosisToxicDrugs/toxins/herbalsVascularBudd-ChiariSinusoidal obstruction syndromeCongenital heart diseaseConstrictive pericarditisHeart failureLiver traumaHereditary hemorrhagic telangiectasiaNeoplasticLangerhans cell histiocytosisLeukemiaLymphomaHepatocellular carcinomaCholangiocarcinomaOther tumors of liver or bile ductsOtherCholedochal cystCaroli diseaseCholedocholithiasisSickle-cell diseasePostnecrotic cirrhosis

Everyone involved in the care of children recognizes the obesity crisis that is so highly prevalent in the USA and is also sweeping the rest of the developed world. This single factor accounts for the majority of new referrals of children with elevated transaminases in the USA as a result of nonalcoholic fatty liver disease (NAFLD) (see 10.1007/978-1-4614-9005-0_18). This was an uncommon diagnosis 25 years ago, and despite multicenter collaborative efforts to design treatments for this condition, it is likely that the solution, if one is to be forthcoming, will be in the realm of public policy development to curtail obesity rather than single-patient medical management.

Gall stones and gall bladder disease can cause jaundice and elevated transaminases and increase as adulthood approaches (see 10.1007/978-1-4614-9005-0_20). Gilbert syndrome is an essentially benign condition manifest as an unconjugated jaundice with normal transaminases. The jaundice is frequently first noted around the time of puberty and these patients are often referred to liver clinics. As for younger children, elevated transaminases with no jaundice may be seen in many liver diseases, but muscle injury, myositis, muscular dystrophy, or cardiomyopathy should not be dismissed without a careful history, physical examination, and a creatine kinase level.

Chronic liver disease may present at any age (see 10.1007/978-1-4614-9005-0_25 and 10.1007/978-1-4614-9005-0_26). As disease progresses jaundice may eventually appear. Abdominal distention from hepatomegaly or ascites may rarely lead to the request for medical attention. More commonly isolated splenomegaly is identified, and if portal hypertension is not considered, the child or teenager may go through detailed hematological investigations unnecessarily. Extrahepatic portal hypertension, due to portal vein thrombosis having occurred usually years before frequently in infancy related to umbilical sepsis or catheterization, can present with splenomegaly. Alternatively, the detection of portal hypertension may be the first sign of chronic liver injury, for example, in autoimmune hepatitis or chronic viral hepatitis, resulting in cirrhosis, but with no history of previous ill health in the child (see Table [6.11](#Tab11){ref-type="table"}). In these circumstances the liver is usually shrunken, and therefore not palpable, but on imaging is heterogenous and nodular and the biopsy specimen severely fibrotic.Table 6.11Causes of portal hypertensionPost-hepaticHeart failureCardiomyopathyCongenital heart diseaseConstrictive pericarditisInferior vena caval thrombosisCongenital web in inferior vena cavaBudd-Chiari syndromeTumorIntrahepatic Post-sinusoidalVeno-occlusive disease SinusoidalCirrhosisNodular regenerative hyperplasiaHypervitaminosis A Pre-sinusoidalSchistosomiasisCongenital hepatic fibrosisSarcoidosisPortosclerosisHepatic artery-portal vein fistulaPre-hepaticPortal vein thrombosisPortal vein stenosisCavernous transformation of portal veinCongenital anomalies of portal veinTumorSinistral (left sided)Splenic vein thrombosisPancreatitisPancreatic pseudocystTumorRetroperitoneal fibrosisRetroperitoneal abscess

With increasing age the incidence of embryonal tumors diminishes and the risk of HCC and metastatic liver tumors increases (see Table [6.12](#Tab12){ref-type="table"}). Greatest risk for HCC is in association with chronic fibrotic liver disease, but the fibrolamellar variant can be encountered in the adolescent without preexisting liver disease. Benign lesions can get big enough to present as a mass or with abdominal discomfort and include nodular regenerative hyperplasia, focal nodular hyperplasia, and adenoma. Leukemias and lymphomas are the most common cancers in children and adolescents and may present with evidence of liver infiltration causing deranged liver function.Table 6.12Causes of hepatic masses beyond infancy - found either on physical examination or imagingNeoplastic MalignantHepatoblastomaHepatocellular carcinomaNeuroblastomaNeuroendocrine tumorsRhabdoid tumorRhabdomyosarcomaEmbryonal sarcomaEpithelioid hemangioendotheliomaCholangiocarcinomaHepatic teratomaOther primary hepatic malignancyMetastatic malignancy in liver BenignAdenomaMesenchymal hamartomaFibronodular hyperplasiaHemangiomaInfectiousAmebic abscessHydatid (Echinococcus)Pyogenic liver abscessOtherNodular regenerative hyperplasiaSimple cystHematomaMucocele of gallbladderCholedochal cystFocal fatty infiltrationRiedel's lobe

Although identification of asymptomatic chronic viral hepatitis via at-risk screening (immigration or infected family) is less common in this age group, they do occur. Adoptees and recent immigrants from HBV endemic regions may present with chronic HBV carriage for management advice. Additionally, family screening because of hereditary hemochromatosis may identify an older child with biochemical evidence of iron overload but normal or mildly altered transaminases (see 10.1007/978-1-4614-9005-0_9). Similarly, a diagnosis of Wilson disease mandates the screening of all first-degree relatives, including other children, before signs of liver injury exist.

Acute Liver Disease and Failure {#Sec11}
-------------------------------

Acute liver disease is the recent onset of liver dysfunction in a patient with no history or investigational evidence of preexisting liver disease (see Table [6.13](#Tab13){ref-type="table"}). This gets a little convoluted when one considers the acute onset of, say, Wilson disease, acute decompensation of chronic hepatitis B, or autoimmune liver disease, where the clinical picture is of a disease of no longer than a few weeks duration but in whom the liver biopsy shows established fibrosis. As is the convention for this chapter in general, we will limit the discussion to the clinical phenotype, i.e., those who have an apparent acute onset of disease with no history of preexisting liver disease.Table 6.13Causes of acute liver failure outside of infancyViralHepatitis AHepatitis BHepatitis DHepatitis EHerpes simplexEpstein-Barr virusVaricella zosterParamyxovirusAdenovirusParvovirus B19SARSHemorrhagic fever virusesBacterialSepticemiaLeptospirosisSalmonella typhi/paratyphiBartonellaRocky Mountain spotted feverMetabolicHereditary fructose intoleranceUrea cycle disordersOrganic acidemiasFatty acid oxidation defectsMitochondrial disordersCarnitine defectsWilson diseaseTyrosinemia type 1Acute fatty liver of pregnancyImmuneAutoimmune hepatitisHemophagocytic lymphohistiocytosisToxicDrugs/toxins/herbalsAmanita phalloidesVascularBudd-ChiariSinusoidal obstruction syndromeIschemic hepatitis/shock liverPost-cardiac surgeryLiver traumaNeoplasticLeukemiaLymphomaHepatocellular carcinomaOtherReye syndromeHypothermiaHeat strokeMassive liver resectionSickle-cell anemia

Acute liver failure results from massive or submassive hepatocellular necrosis, but the syndrome is defined in terms of the duration of the illness (less than 8 weeks) and the presence of coagulopathy and hepatic encephalopathy (see 10.1007/978-1-4614-9005-0_23 for more details). One important consideration is to differentiate between the acute failure of liver functions manifest by coagulopathy, cholestasis, hyperammonemia, loss of glycemic control, encephalopathy, etc., and the criteria for entry into the PALF (Pediatric Acute Liver Failure) study. In an attempt to be inclusive and to observe the progression from early disease to liver failure, the criteria for entry into PALF were set relatively low, namely, coagulopathy secondary to acute liver disease with an INR of ≥1.5 with hepatic encephalopathy or ≥2.0 in the absence of encephalopathy. There was never an intention to liberalize the definition of acute liver failure, and yet more and more frequently, these study entry criteria are being quoted as the "definition" of acute liver failure which they patently are not.

Differentiating between the causes of acute liver failure can be challenging. Nonspecific metabolic derangement adds another level of complication to identifying a liver based-metabolic disease. Similar challenges to acute diagnosis exist with many other causes, and great care is required to not miss a potentially treatable cause of liver disease such as autoimmune hepatitis or Wilson disease. Although the single largest group of acute liver failure patients in childhood is those in whom a specific etiology is not identified, it does not negate the need for a full and detailed workup. Sadly, even in the context of a multicenter study with recommendations made for appropriate investigation, inadequate investigation of cause is frequently encountered \[[@CR9]\].

There may be clues such as a history of medication or herbal ingestion (see 10.1007/978-1-4614-9005-0_19), encephalopathy that is fluctuating or out of proportion to the liver dysfunction may point towards a mitochondrial or other metabolic disease, hemolysis can suggest Wilson disease, or foreign travel increasing the likelihood of an infectious cause. Unfortunately these features are neither specific nor sensitive, and as much as we may like to narrow our differential diagnosis to address the most likely or most serious diagnoses first, in the situation of acute hepatic failure, all causes are life-threateningly serious, and therefore, an inclusive panel of investigation is the safest and most efficient approach. Clearly, investigations, especially for infectious causes, will be tempered by knowledge of local occurrence; we in Seattle do not, for example, routinely check for the flavivirus that causes yellow fever. For more details on the approach to acute liver failure, see 10.1007/978-1-4614-9005-0_23.

Consult from Other Services with Liver Dysfunction in Association with Known Disease {#Sec12}
------------------------------------------------------------------------------------

When a consult comes in from another specialist service, there is always the possibility that the liver disease has nothing to do with the condition that the specialist has been managing. This is essentially a caution because the referral from cardiology of the child with Eisenmenger syndrome, abnormal transaminases, and mild splenomegaly may automatically become hepatic congestion and portal hypertension secondary to right heart failure, while their autoimmune hepatitis goes unrecognized and untreated! Therefore, no matter who the originator of the referral is, the approach to differential diagnosis should be based on the child themselves as outlined in the sections above. Having said this, there is probably a different weighting of the diagnostic possibilities in patients with non-liver diseases with known hepatic pathological associations. Table [6.14](#Tab14){ref-type="table"} lists some of the particular diagnostic considerations based on the specialty team requesting a hepatological consultation on one of their patients.Table 6.14Conditions in other organ systems associated with recognized patterns of liver involvement(A) Gastroenterology (i) Inflammatory bowel disease associated with sclerosing cholangitis or autoimmune hepatitis (ii) Celiac disease associated with autoimmune hepatitis (iii) Parenteral nutrition-associated liver disease in patients with intestinal failure (iv) Shwachman-Diamond syndrome -- pancreatic insufficiency and neutropenia often associated with hepatomegaly and transaminitis(B) Cardiology (i) Fontan circulation with ascites (ii) Heart failure associated with hepatosplenomegaly, hepatic fibrosis, and sinusoidal dilation (iii) Cardiac surgery leading to shock liver (ischemic hepatitis) and acute liver failure (iv) Alagille syndrome (v) Constrictive pericarditis (vi) Cardiomyopathy(C) Hematology/oncology (i) Sinusoidal obstruction syndrome (ii) Drug effect (iii) Hemolysis leading to biliary inspissation/sludge/stones (iv) Sickle liver (v) Transfusion-related iron overload (vi) Transfusion-related infectious hepatitis (vii) Budd-Chiari  (a) Hypercoagulable states  (b) Myeloproliferative disorders  (c) Paroxysmal nocturnal hemoglobinuria (viii) Leukemia and lymphoma (ix) Langerhans cell histiocytosis (x) Liver tumors (xi) Stem cell transplantation  (a) Graft versus host disease  (b) Sinusoidal obstruction syndrome  (c) Opportunistic liver infections(D) Pulmonology (i) Cystic fibrosis liver disease (ii) Sarcoidosis (iii) Tuberculosis(E) Nephrology (i) Polycystic kidney disease, nephronophthisis (ii) Alagille syndrome (iii) Membranoproliferative glomerulonephritis associated with portal hypertension(F) Endocrine (i) Nonalcoholic steatohepatitis (ii) Diabetic glycogen hepatopathy (Mauriac syndrome) (iii) Hypopituitarism (iv) Autoimmune polyendocrine syndrome type 1 (v) McCune-Albright syndrome (vi) Generalized lipodystrophy (Berardinelli-Seip syndrome)(G) Immunology (i) Immunodeficiencies associated with sclerosing cholangitis or hepatic abscess (ii) Granulomatous hepatitis in chronic granulomatous disease (CDG) (iii) Wegener's granulomatosis (iv) Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked (IPEX) (v) Hyper-IgM syndrome (CD40 ligand deficiency) (vi) HIV particularly congenitally acquired(H) Rheumatology (i) Systemic lupus erythematosus (ii) Systemic juvenile idiopathic arthritis (JIA) (iii) Juvenile dermatomyositis (iv) Macrophage activation syndrome (v) Secondary amyloidosis(I) Genetics (i) Liver abnormalities as part of multisystem syndromes

Other Phenotypes {#Sec13}
----------------

Although singly or in combination jaundice, hepatitis, hepatomegaly, or liver mass account for the majority of new presentations of liver disease in childhood, occasionally none of these features are immediately obvious and in some cases absent completely (see Table [6.15](#Tab15){ref-type="table"}). Pruritus in the absence of jaundice can rarely be due to cholestasis, although dermatological causes are far more prevalent. Gastrointestinal bleeding from esophageal varices or ascites usually occurs in the presence of recognized chronic liver disease but in some cases are the first overt signs of its presence. Variceal bleeding as a first presenting feature is seen not uncommonly in cavernous transformation of the portal vein secondary to temporally distant portal vein thrombosis. The child or teenager with isolate splenomegaly may be found to have developed cirrhosis with no past history of jaundice or other features of liver disease. Finally, a few infants and toddlers may manifest with hypocalcemic tetany or rickets and be found to have profound fat-soluble vitamin deficiency. If due to liver disease, other features almost always are present with the notable exception of defects of bile acid amidation (see 10.1007/978-1-4614-9005-0_8).Table 6.15Differential diagnosis for clinical signs that may suggest liver disease presenting without jaundice, hepatomegaly, or elevated transaminases(a) Isolated splenomegaly (i) Portal hypertension (causes of portal hypertension, see Table [6.15](#Tab15){ref-type="table"}) (ii) Anemia (iii) Infection (iv) Sequestration, e.g., sickle-cell disease (v) Metabolic storage diseases (vi) Cancer (vii) Immune, e.g., Felty syndrome, macrophage activation(b) Ascites (i) Portal hypertension (ii) Fontan circulation, heart failure, constrictive pericarditis (iii) Infection -- peritonitis, tuberculosis (iv) Cancer (v) Lymphatic dysplasia (vi) Nephrotic syndrome (vii) Trauma -- lymphatic, urinary (viii) Vasculitis, serositis (ix) Kwashiorkor (x) Pseudo-ascites, e.g., giant omental cyst (Fig. [6.2](#Fig2){ref-type="fig"})(c) Pruritus (i) Anicteric cholestasis (ii) Acute and chronic dermatological conditions (iii) Cutaneous allergic reactions (iv) Drug reaction (v) Opiate withdrawal (vi) Psychological (vii) Renal failure(d) Gastrointestinal bleeding (i) Varices (usually esophageal or gastric) (ii) Peptic ulcer (iii) Mallory-Weiss tear (iv) Hemorrhoids (v) Inflammatory bowel disease (vi) Meckel's diverticulum (vii) Polyps (viii) Cancer (ix) Trauma/ingestion (x) Intestinal vasculitis, e.g., Henoch-Schönlein purpura (xi) Angiodysplasia(e) Metabolic bone disease/hypocalcemia (i) Nutritional vitamin/calcium/phosphorus deficiency (ii) Fat-soluble vitamin malabsorption  1. Anicteric cholestasis  2. Bile acid deficiency   (a) Ingestion of bile acid binders   (b) External biliary drainage   (c) Bile acid synthesis and conjugation defects  3. Celiac disease  4. Pancreatic insufficiency  5. Lymphangiectasia (iii) Hypoparathyroidism
